Table 2 Baseline characteristics of the withdrawal subgroup

Male/Female

19/31

1/4

Age at inclusion, years [median (range)]

38 (18–75)

26(19–68)

Duration of hospital stay, days[median (range)]

7(3–9)

7(5–7)

Diagnosis

FE

1

4

GGE

1

-

PNES

36

-

-

FE/PNES

-

1

GGE/PNES

1

-

ASS

4

-

FTS

3

-

UE

2

-

Other

2

-

Age at seizure onset, years [median (range)]

30,5 (2–74)

21(12–67)

Febrile seizures yes/no/unknown

1/40/9

0/4/1

Cerebral trauma yes/no/unknown

10/38/3

1/3/1

History of CNS-Infection yes/no/unknown

4/44/2

1/4/0

Positive family history yes/no/unknown

9/36/5

0/4/1

Withdrawal group

Group 1

2

-

Group 2

42

2

Group 3

Group 4

6

-

3

-

Seizure free interval, months [median (range)]

0 (0-240)

5(0–60)

Number of ASM taken before withdrawal, [median (range)]

1 (1–13)

2 (1–2)

Duration of ASM treatment before withdrawal, months [median (range)]

13,5 (1-348)

48 (3–81)